What I don't get is why now just out of the blue. I get the idea that with all the ongoing anti-viral testing they would now focus on anti-infection development. My thought is K could have just sat on the shelf as a future development for years. I hope this sudden change is because B has given them so much confidence to do so.
Market Data 
Markets 
AI
